ACC

Clinical trials for ACC explained in plain language.

Never miss a new study

Get alerted when new ACC trials appear

Sign up with your email to follow new studies for ACC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New combo therapy aims to safely treat rare adrenal cancer

Symptom relief Recruiting now

This study tests whether giving the drug pembrolizumab after standard radiation therapy is safe for people with advanced adrenocortical carcinoma (a rare adrenal gland cancer). The trial will enroll 12 participants and focus on tracking side effects. The goal is to see if this co…

Matched conditions: ACC

Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Symptom relief

Last updated May 20, 2026 11:57 UTC

ACC

Get alerted when new ACC trials appear

New combo therapy aims to safely treat rare adrenal cancer